Publication Name	World Journal of Hepatology
Manuscript ID	29457
Country	United States

Received	2016-08-15 10:06
Peer-Review Started	2016-08-23 16:52
To Make the First Decision	2016-09-05 09:22
Return for Revision	2016-09-06 09:23
Revised	2016-09-20 11:03
Second Decision	2016-10-10 09:40
Accepted by Journal Editor-in-Chief	2016-10-10 12:49
Accepted by Executive Editor-in-Chief	2016-10-24 14:55
Articles in Press	2016-10-24 14:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-12 10:02
Publish the Manuscript Online	2016-12-15 16:07

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Cohort Study
Article Title	Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
Manuscript Source	Unsolicited Manuscript
All Author List	Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren and Dawn Torres
Funding Agency and Grant Number
Corresponding Author	Amilcar L Morales, MD, Transplant Hepatology Staff, Hepatology Service, San Antonio Military Medical Center, 3551 Roger Brooke Dr, Fort Sam Houston, San Antonio, TX 78234, United States. amcardona2002@yahoo.com
Key Words	Hepatitis C; Sofosbuvir; Hyperlipidemia; Hemoglobin A1c; Low-density lipoprotein
Core Tip	In our retrospective study, we evaluated the changes in glucose and lipid metabolism in a group of hepatitis C patients treated and cured with a sofosbuvir-containing regimen. We used hemoglobin A1c (HgA1c) and lipid panels to assess those two parameters. Six months post eradication, we found a statistically significant drop in HgA1c and an increase in low-density lipoprotein and total cholesterol. The use of HgA1c, although not perfect, is easy to understand and is frequently used by primary care doctors as a tool to assess glucose control.
Publish Date	2016-12-15 16:07
Citation	Morales AL, Junga Z, Singla MB, Sjogren M, Torres D. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World J Hepatol 2016; 8(35): 1557-1563
URL	http://www.wjgnet.com/1948-5182/full/v8/i35/1557.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i35.1557

Full Article (PDF)	WJH-8-1557.pdf
Full Article (Word)	WJH-8-1557.doc
Manuscript File	29457-Review.docx
Answering Reviewers	29457-Answering reviewers.pdf
Audio Core Tip	29457-Audio core tip.mp3
Biostatistics Review Certificate	29457-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	29457-Conflict-of-interest statement.pdf
Copyright License Agreement	29457-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	29457-Institutional review board statement.pdf
Peer-review Report	29457-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	29457-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	29457-Scientific misconduct check.pdf
Scientific Editor Work List	29457-Scientific editor work list.pdf